UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 164

Sortiert nach

Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy

The New England journal of medicine, 2021-02, Vol.384 (7), p.630-642

2021

Link zum Volltext

Verfügbarkeit prüfen

Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study

Fertility and sterility, 2017-07, Vol.108 (1), p.152-160.e4

2017

Link zum Volltext

Verfügbarkeit prüfen

Health-Related Quality of Life With Ulipristal Acetate for Treatment of Uterine Leiomyomas: A Randomized Controlled Trial

Obstetrics and gynecology (New York. 1953), 2019-05, Vol.133 (5), p.869

2019

Link zum Volltext

Verfügbarkeit prüfen

Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas

Obstetrics and gynecology (New York. 1953), 2022-12, Vol.140 (6), p.920

2022

Link zum Volltext

Verfügbarkeit prüfen

Relugolix Combination Therapy for Uterine Leiomyoma-Associated Pain in the LIBERTY Randomized Trials

Obstetrics and gynecology (New York. 1953), 2022-06, Vol.139 (6), p.1070

2022

Link zum Volltext

Verfügbarkeit prüfen

Quality of life improvements in women with uterine fibroids treated with relugolix combination therapy during the LIBERTY long‐term extension study: A descriptive subgroup analysis in women with anemia at baseline

International journal of gynecology and obstetrics, 2024-05, Vol.165 (2), p.431-441

2024

Link zum Volltext

Verfügbarkeit prüfen

LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids

American journal of obstetrics and gynecology, 2023-12, Vol.229 (6), p.662.e1-662.e25

2023

Link zum Volltext

Verfügbarkeit prüfen

Relugolix combination therapy in Black/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study

American journal of obstetrics and gynecology, 2024-02, Vol.230 (2), p.237.e1-237.e11

2024

Link zum Volltext

Verfügbarkeit prüfen

Twelve-Month Outcomes for Patients Undergoing Hysteroscopic Morcellation of Uterine Polyps and Myomas in an Office or Ambulatory Surgical Center

Journal of minimally invasive gynecology, 2015-02, Vol.22 (2), p.285-290

2015

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of an adjuvanted Escherichia coli adhesin vaccine in healthy women with and without histories of recurrent urinary tract infections: results from a first-in-human phase 1 study

Human vaccines & immunotherapeutics, 2021-05, Vol.17 (5), p.1262-1270

2021

Link zum Volltext

Verfügbarkeit prüfen

Tranexamic Acid Treatment for Heavy Menstrual Bleeding: A Randomized Controlled Trial

Obstetrics and gynecology (New York. 1953), 2010-10, Vol.116 (4), p.865-875

2010

Link zum Volltext

Verfügbarkeit prüfen

12-month outcomes of the US patient cohort in the SONATA pivotal IDE trial of transcervical ablation of uterine fibroids

International journal of women's health, 2019-07, Vol.11, p.387-394

2019

Link zum Volltext

Verfügbarkeit prüfen

Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders

Fertility and sterility, 2008-09, Vol.90 (3), p.673-677

2008

Link zum Volltext

Verfügbarkeit prüfen

Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid

British journal of haematology, 2009-04, Vol.145 (2), p.212-220

2009

Link zum Volltext

Verfügbarkeit prüfen

Experience of Symptoms and Disease Impact in Patients with Adenomyosis

The patient : patient-centered outcomes research, 2018-06, Vol.11 (3), p.319-328

2018

Link zum Volltext

Verfügbarkeit prüfen

A plain language summary of the safety of relugolix combination therapy and improvement in symptoms in women with uterine fibroids from the LIBERTY 1 and LIBERTY 2 studies

Pain management (London), 2023-04, Vol.13 (4), p.205-211

2023

Link zum Volltext

Verfügbarkeit prüfen

A dose-response study of a novel, oral tranexamic formulation for heavy menstrual bleeding

American journal of obstetrics and gynecology, 2011-10, Vol.205 (4), p.319.e1-319.e7

2011

Link zum Volltext

Verfügbarkeit prüfen

Estimating a meaningful reduction in menstrual blood loss for women with heavy menstrual bleeding

Current medical research and opinion, 2010-11, Vol.26 (11), p.2673-2678

2010

Link zum Volltext

Verfügbarkeit prüfen

New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings

The American journal of medicine, 1994-03, Vol.96 (3), p.200-209

1994

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of a screening tool for bleeding disorders in a US multisite cohort of women with menorrhagia

American journal of obstetrics and gynecology, 2011-03, Vol.204 (3), p.209.e1-209.e7

2011

Link zum Volltext

Verfügbarkeit prüfen

Daily menstrual blood loss and quality of life in women with heavy menstrual bleeding

Women's health (London, England), 2012-09, Vol.8 (5), p.503-511

2012

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness of Global Endometrial Ablation vs. Hysterectomy for Treatment of Abnormal Uterine Bleeding: US Commercial and Medicaid Payer Perspectives

Population health management, 2015-10, Vol.18 (5), p.373

2015

Link zum Volltext

Verfügbarkeit prüfen

Improved Premenstrual Syndrome Symptoms after NovaSure Endometrial Ablation

Journal of minimally invasive gynecology, 2011-09, Vol.18 (5), p.607-611

2011

Link zum Volltext

Verfügbarkeit prüfen

Abnormal uterine bleeding and underlying hemostatic disorders: report of a consensus process

Fertility and sterility, 2005-11, Vol.84 (5), p.1335-1337

2005

Link zum Volltext

Verfügbarkeit prüfen

Cost effectiveness of endometrial ablation with the NovaSure(®) system versus other global ablation modalities and hysterectomy for treatment of abnormal uterine bleeding: US commercial and Medicaid payer perspectives

International journal of women's health, 2015-01, Vol.7 (default), p.59-73

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 164

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(150)
Mit Volltextzugriff
(146)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(129)
Life Sciences & Biomedicine
(118)
Humans
(101)
Female
(72)
Adult
(48)
Middle Aged
(34)
Obstetrics & Gynecology
(33)
Male
(32)
Young Adult
(20)
Adolescent
(18)
Public, Environmental & Occupational Health
(18)
Treatment Outcome
(18)
General & Internal Medicine
(17)
Menorrhagia
(16)
Surgery
(16)
Menorrhagia - Drug Therapy
(15)
Quality Of Life
(15)
Aged
(14)
Health Care Sciences & Services
(14)
Medicine, General & Internal
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy

Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study

Health-Related Quality of Life With Ulipristal Acetate for Treatment of Uterine Leiomyomas: A Randomized Controlled Trial

Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas

Relugolix Combination Therapy for Uterine Leiomyoma-Associated Pain in the LIBERTY Randomized Trials

Quality of life improvements in women with uterine fibroids treated with relugolix combination therapy during the LIBERTY long‐term extension study: A descriptive subgroup analysis in women with anemia at baseline

LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids

Relugolix combination therapy in Black/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study

Twelve-Month Outcomes for Patients Undergoing Hysteroscopic Morcellation of Uterine Polyps and Myomas in an Office or Ambulatory Surgical Center

Safety and immunogenicity of an adjuvanted Escherichia coli adhesin vaccine in healthy women with and without histories of recurrent urinary tract infections: results from a first-in-human phase 1 study

Tranexamic Acid Treatment for Heavy Menstrual Bleeding: A Randomized Controlled Trial

12-month outcomes of the US patient cohort in the SONATA pivotal IDE trial of transcervical ablation of uterine fibroids

Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders

Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid

Experience of Symptoms and Disease Impact in Patients with Adenomyosis

A plain language summary of the safety of relugolix combination therapy and improvement in symptoms in women with uterine fibroids from the LIBERTY 1 and LIBERTY 2 studies

A dose-response study of a novel, oral tranexamic formulation for heavy menstrual bleeding

Estimating a meaningful reduction in menstrual blood loss for women with heavy menstrual bleeding

New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings

Evaluation of a screening tool for bleeding disorders in a US multisite cohort of women with menorrhagia

Daily menstrual blood loss and quality of life in women with heavy menstrual bleeding

Cost-Effectiveness of Global Endometrial Ablation vs. Hysterectomy for Treatment of Abnormal Uterine Bleeding: US Commercial and Medicaid Payer Perspectives

Improved Premenstrual Syndrome Symptoms after NovaSure Endometrial Ablation

Abnormal uterine bleeding and underlying hemostatic disorders: report of a consensus process

Cost effectiveness of endometrial ablation with the NovaSure(®) system versus other global ablation modalities and hysterectomy for treatment of abnormal uterine bleeding: US commercial and Medicaid payer perspectives

Suchergebnisse filtern